COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Multiple vaccines have recently been developed, and almost all the countries are presently vaccinating their population to tackle the COVID-19 pandemic. Most of the COVID-19 vaccines in use are administered via intramuscular (IM) injection, eliciting protective humor and cellular immunity. COVID-19...
Saved in:
Main Authors: | Kuldeep Dhama (Author), Manish Dhawan (Author), Ruchi Tiwari (Author), Talha Bin Emran (Author), Saikat Mitra (Author), Ali A. Rabaan (Author), Saad Alhumaid (Author), Zainab Al Alawi (Author), Abbas Al Mutair (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges
by: Tapas Kumar Goswami, et al.
Published: (2022) -
COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic
by: Kuldeep Dhama, et al.
Published: (2021) -
Prophylactic and therapeutic insights into trained immunity: A renewed concept of innate immune memory
by: Suresh Bindu, et al.
Published: (2022) -
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines
by: Md. Jamal Hossain, et al.
Published: (2022) -
Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
by: Khan Sharun, et al.
Published: (2021)